The Optimal Time of Percutaneous Pharmacomechanical Thrombolysis for the Treatment of Thrombosed Hemodialysis Arteriovenous Graft
Seminars in Dialysis · 2025
DOI: 10.1111/sdi.13251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Dialysis, 2025. Verfasst von Keerati Hongsakul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Graft Occlusion, Vascular, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
The optimal time for the salvaging of thrombosed hemodialysis grafts is controversial. This study was aimed at determining the optimal time related to the outcome of percutaneous pharmacomechanical thrombolysis (PMT) for the treatment of thrombosed arteriovenous graft (AVG).
Methods
This was a retrospective study of 191 hemodialysis patients who underwent PMT for thrombosed AVG from April 2014 to December 2021. Demographic data and details of the procedure were recorded. The procedural success rate related to the onset time of PMT was analyzed. The postinterventional circuit primary assisted patency rate was presented by the Kaplan–Meier curve.
Results
A total of 191 hemodialysis patients, 101 females and 90 males, were enrolled. Their median age was 66 years (interquartile range of 58–75 years). The majority type of thrombosed AVG was brachiocephalic loop graft (60.2%). The procedural success rate of PMT that was performed ≤ 48 h was 86.2%. There was a statistically significant procedural success rate of PMT in the group with an onset of treatment ≤ 48 h compared to > 48 h (odds ratio = 2.77; 95% confidence interval = 1.06, 7.28; p = 0.037). The median postintervention circuit primary assisted patency in the group of treatment ≤ 48 and > 48 h was 7.3 and 3.9 months ( p = 0.023), respectively.
Conclusion
From this study, the optimal time of PMT for treatment of thrombosed AVG should be within 48 h after onset of thrombosis for enhancing procedural success and patency rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Interventional Radiology, Department of Radiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
- Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
ORCID-Profile: Keerati Hongsakul
Zitieren
APA
Hongsakul, K., Srihasarn, S., Janjindamai, P., Akkakrisee, S., Bannangkoon, K., Rookkapan, S., & Boonsrirat, U. (2025). The Optimal Time of Percutaneous Pharmacomechanical Thrombolysis for the Treatment of Thrombosed Hemodialysis Arteriovenous Graft. Seminars in Dialysis. https://doi.org/10.1111/sdi.13251
Vancouver
Hongsakul K, Srihasarn S, Janjindamai P, Akkakrisee S, Bannangkoon K, Rookkapan S, et al. The Optimal Time of Percutaneous Pharmacomechanical Thrombolysis for the Treatment of Thrombosed Hemodialysis Arteriovenous Graft. Seminars in Dialysis. 2025. doi:10.1111/sdi.13251
BibTeX
@article{Hongsakul2025,
author = {Hongsakul, Keerati and Srihasarn, Surasee and Janjindamai, Phurich and Akkakrisee, Surasit and Bannangkoon, Kittipitch and Rookkapan, Sorracha and Boonsrirat, Ussanee},
title = {The Optimal Time of Percutaneous Pharmacomechanical Thrombolysis for the Treatment of Thrombosed Hemodialysis Arteriovenous Graft},
journal = {Seminars in Dialysis},
year = {2025},
doi = {10.1111/sdi.13251}
}
EUVIMED